Frank Jaschinski, Ph.D.Chief Scientific Officer at Secarna Pharmaceuticals
As CSO of Secarna Pharmaceuticals, Frank Jaschinski is responsible for the scientific progress of Secarna’s programms. After receiving his PhD in biochemistry at the University of Zürich in 2001, he entered The Genetics Company, a biotech startup in Switzerland. In 2006 he joined the department of preclinical research & development of Antisense Pharma. During the transition of Antisense Pharma into Isarna Therapeutics, he was responsible for the generation of a new pipeline of antisense oligonucleotides against TGF-beta. In 2015 he joined Secarna Pharmaceuticals as Chief Science Officer.